Found 35 matching trials
Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser Ablation
PHASE4Endothermal heat-induced thrombosis (EHIT) is a thrombotic complication spe...
Location
Heart Artery and Vein Center of Fresno
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis
PHASE4This trial aims to compare the safety and efficacy of apixaban alone versus...
Location
Multiple Locations
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
PHASE3A multi-center adaptive randomized placebo-controlled platform trial evalua...
Location
University of Southern California
REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.
PHASE3Patients with unprovoked venous thromboembolism (VTE) or VTE associated wit...
Location
CHU Amiens-Picardie
COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
PHASE4Atrial Fibrillation (AF) affects 200,000 Canadians and increases risk of st...
Location
Victoria Cardiac Arrhythmia Trials
Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus
PHASE1This study aims to evaluate the pharmacokinetics (PK) of apixaban when co-a...
Location
Thomas Jefferson University
Bleeding Risk With Apixaban Versus Rivaroxaban in Acute Pulmonary Embolism
NAThis prospective, open-label, randomized controlled trial will compare clin...
Location
Combined Military Hospital Lahore
PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers
PHASE1This study aims to evaluate the effects of combination therapy of tegopraza...
Location
Jeonbuk National University Hospital
DIrect Oral Anticoagulation and Bioprothesis Aortic Valve
PHASE3DIAMOND study is a national, multicentre, randomized, parallel-group, open ...
Location
Service de Cardiologie Hôpital Lariboisière
Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents
PHASE4Atrial fibrillation patients with risk factors for stroke and systemic embo...
Status
Active Not Recruiting
Location
Severance Cardiovascular Hospital, Yonsei University Health System